Combination of mAb cG250 with natural killer cells for RCC treatment
Jeannette Oosterwijk‐Wakka(Radboud University Nijmegen), Egbert Oosterwijk(Radboud University Nijmegen), Peter F.A. Mulders(Radboud University Nijmegen), S. Lafferty-Van Eijk, Paul K.J.D. de Jonge(Radboud University Nijmegen), P.M.M. van Hauten(Radboud University Nijmegen), Ralph J. A. Maas(Radboud University Nijmegen), Harry Dolstra(Radboud University Nijmegen)
Cited by 0
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
|European Urology|2016|414
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2012|275